A multi-analyte panel for non-invasive pharmacokinetic monitoring of second-line anti-tuberculosis drugs.
Maternal-Fetal Medicine Division, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco (UCSF), USA.
Roy
R
Gerona
Maternal-Fetal Medicine Division, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco (UCSF), USA.
Anita
A
Wen
Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, UCSF, USA.
Catherine
C
Koss
Department of Epidemiology and Biostatistics, UCSF, USA.
Peter
P
Bacchetti
Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, UCSF, USA.
Monica
M
Gandhi
Curry International Tuberculosis Center, Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, UCSF, California, USA. john.metcalfe@ucsf.edu.
John
J
Metcalfe
D000995:Antitubercular Agents / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D002853:Chromatography, Liquid; D016903:Drug Monitoring / Q000379:methods*; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D021241:Spectrometry, Mass, Electrospray Ionization; D053719:Tandem Mass Spectrometry; D018088:Tuberculosis, Multidrug-Resistant / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology
D000995:Antitubercular Agents